ArticleInfectious diseases & clinical microbiology2025
Measles: The Re-emergence of a Vaccine-Preventable Disease.
Article in Infectious diseases & clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The measles virus is one of the most infectious pathogens known. Although measles is typically self-limiting, it can result in complications such as otitis media, pneumonia, and encephalitis. This retrospective study aimed to examine the epidemiological characteristics, such as age, gender, and vaccination status, of confirmed and probable measles cases. Materials and Methods: Adults aged ≥18 years diagnosed with confirmed or probable measles between 2019 and 2023 in a single province were included in the study. Age, gender, serologic test results, vaccination status, clinical features, and complications were analyzed retrospectively. Results: A total of 193 adult patients with a preliminary diagnosis of measles were included. The mean age was 31.4 ± 7.7 years, and 80.8% were female. Vaccination status was unknown in 80.3% of patients, 14% reported no history of measles vaccination. Clinical features included maculopapular rash (76.7%), fever (68.4%), conjunctivitis (60.1%), and Koplik's spots (43%). Of the patients, 52 (26.9%) were diagnosed with confirmed measles based on positive measles-specific immunoglobulin M (IgM), while 141 (73.1%) were evaluated as probable measles based on clinical presentation. Pneumonia was observed in 2 (1%) patients. A total of 22 (11.4%) patients were hospitalized for follow-up and treatment, with hospitalization periods ranging from two to eight days. No statistically significant differences were observed between confirmed and probable cases regarding age, gender, vaccination status, fever, rash, conjunctivitis, or pneumonia (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.